title: Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report.
authors.affiliation: Department of Dermatology, Safdarjung Hospital, 110029 New Delhi, India.
authors.forename: Venkat
authors.initials: V
authors.lastname: Ramesh
authors.forename: Kumar
authors.initials: K
authors.lastname: Avishek
authors.forename: Vanila
authors.initials: V
authors.lastname: Sharma
authors.forename: Poonam
authors.initials: P
authors.lastname: Salotra
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D016054:DNA, Protozoan / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D007898:Leishmaniasis, Visceral / Q000150:complications; D008297:Male; D059208:Parasite Load; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000981:Antiprotozoal Agents; D016054:DNA, Protozoan; D010767:Phosphorylcholine; C039128:miltefosine; D000666:Amphotericin B